A retrospective study to evaluate the response to intravitreal ranibizumab treatment in Japanese patients with exudative age related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2015
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 13 Dec 2015 New trial record